Pleurodesis outcome in malignant pleural mesothelioma

被引：43

作者：

Fysh, Edward Thomas Hamilton ^{[1
,2
]}

Tan, Sze Khen ^{[1
,3
]}

Read, Catherine Ann ^{[1
]}

Lee, Felicity ^{[1
]}

McKenzie, Kate ^{[1
]}

Olsen, Nola ^{[4
]}

Weerasena, Indunil ^{[1
]}

Threlfall, Timothy ^{[5
]}

de Klerk, Nicholas ^{[4
]}

Musk, A. William ^{[1
,4
]}

Lee, Y. C. Gary ^{[1
,2
]}

机构：

[1] Sir Charles Gairdner Hosp, Resp Dept, Perth, WA, Australia

[2] Univ Western Australia, Dept Med, Sch Med & Pharmacol, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia

[3] Khoo Teck Puat Hosp, Dept Gen Med, Singapore, Singapore

[4] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia

[5] Western Australia Dept Hlth, Western Australian Canc Registry, Mt Claremont, WA, Australia

来源：

THORAX | 2013年 / 68卷 / 06期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1136/thoraxjnl-2012-203043

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Few data exist on the pleurodesis outcome in patients with malignant pleural mesothelioma (MPM). A retrospective review of the Western Australian Mesothelioma Registry over 5 years revealed 390 evaluable patients. Only a subset of patients (42.3%) underwent pleurodesis, surgically (n=78) or by bedside instillation of sclerosants (n=87). Surgical pleurodesis showed no advantages over bedside pleurodesis in efficacy (32% vs 31% failures requiring further drainage, p=0.98), patient survival (p=0.52) or total time spent in hospital from procedure till death (p=0.36). No clinical, biochemical or radiographic parameters tested adequately predict pleurodesis outcome.

引用

页码：594 / 596

页数：3

共 5 条

[1] Tumor Type Influences the Effectiveness of Pleurodesis in Malignant Effusions
Bielsa, Silvia
Hernandez, Paula
Rodriguez-Panadero, Francisco
Taberner, Teresa
Salud, Antonieta
Porcel, Jose M.
[J]. LUNG, 2011, 189 (02) : 151 - 155
[2] Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea in Patients With Malignant Pleural Effusion The TIME2 Randomized Controlled Trial
Davies, Helen E.
Mishra, Eleanor K.
Kahan, Brennan C.
Wrightson, John M.
Stanton, Andrew E.
Guhan, Anur
Davies, Christopher W. H.
Grayez, Jamal
Harrison, Richard
Prasad, Anjani
Crosthwaite, Nicola
Lee, Y. C. Gary
Davies, Robert J. O.
Miller, Robert F.
Rahman, Najib M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (22): : 2383 - 2389
[3] Indwelling Pleural Catheters Reduce Inpatient Days Over Pleurodesis for Malignant Pleural Effusion
Fysh, Edward T. H.
Waterer, Grant W.
Kendall, Peter A.
Bremner, Peter R.
Dina, Sharifa
Geelhoed, Elizabeth
McCarney, Kate
Morey, Sue
Millward, Michael
Musk, A. W.
Lee, Y. C. Gary
[J]. CHEST, 2012, 142 (02) : 394 - 400
[4] Thoracoscopic talc poudrage pleurodesis for malignant effusions - A review of 360 cases
Viallat, JR
Rey, F
Astoul, P
Boutin, C
[J]. CHEST, 1996, 110 (06) : 1387 - 1393
[5] Management of malignant pleural mesothelioma
West, Sophie D.
Lee, Y. C. Gary
[J]. CLINICS IN CHEST MEDICINE, 2006, 27 (02) : 335 - +

← 1 →